GE HealthCare Technologies Inc. (GEHC)

NASDAQ: GEHC · Real-Time Price · USD

82.52

+0.14 (0.17%)

At close: Dec 18, 2025, 4:00 PM EST

82.06

-0.46 (-0.56%)

After-hours: Dec 18, 2025, 7:43 PM EST

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2018 - 2020
Product Revenue	13.38B	13.08B	Log In	Log In	Log In	Upgrade
Service Revenue	6.87B	6.60B	Log In	Log In	Log In	Upgrade
Revenue (Other)	-1.00M	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	20.25B	19.67B	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2018 - 2020
Imaging Revenue (Post-Q2 2024)	9.09B	8.86B	Log In	Log In	Log In	Upgrade
Advanced Visualization Solutions (AVS) Revenue	5.27B	5.13B	Log In	Log In	Log In	Upgrade
Patient Care Solutions (PCS) Revenue	3.09B	3.13B	Log In	Log In	Log In	Upgrade
Pharmaceutical Diagnostics (PDx) Revenue	2.76B	2.51B	Log In	Log In	Log In	Upgrade
Other Revenue	47.00M	52.00M	Log In	Log In	Log In	Upgrade
Revenue (Total)	20.25B	19.67B	Log In	Log In	Log In	Upgrade

Revenue Breakdown 3

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2018 - 2020
Patient Care Solutions (PCS) Revenue	3.09B	3.13B	Log In	Log In	Log In	Upgrade
Pharmaceutical Diagnostics (PDx) Revenue	2.76B	2.51B	Log In	Log In	Log In	Upgrade
Other Revenue	47.00M	52.00M	Log In	Log In	Log In	Upgrade
Imaging Revenue	-	-	Log In	Log In	Log In	Upgrade
Ultrasound Revenue	-	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	20.25B	19.67B	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2018 - 2020
USCAN Revenue	9.33B	8.98B	Log In	Log In	Log In	Upgrade
EMEA Revenue	5.24B	5.05B	Log In	Log In	Log In	Upgrade
China Revenue	2.32B	2.36B	Log In	Log In	Log In	Upgrade
Rest of World Revenue	3.36B	3.28B	Log In	Log In	Log In	Upgrade
Revenue (Other)	-3.00M	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	20.25B	19.67B	Log In	Log In	Log In	Upgrade

EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2018 - 2020
Imaging EBIT (Post-Q2 2024)	929.00M	962.00M	Log In	Log In	Log In	Upgrade
Advanced Visualization Solutions (AVS) EBIT	1.17B	1.12B	Log In	Log In	Log In	Upgrade
Patient Care Solutions (PCS) Segment EBIT	241.00M	347.00M	Log In	Log In	Log In	Upgrade
Pharmaceutical Diagnostics (PDx) Segment EBIT	850.00M	783.00M	Log In	Log In	Log In	Upgrade
Other Segment EBIT	6.00M	2.00M	Log In	Log In	Log In	Upgrade
Operating Income (Other)	-462.00M	-587.00M	Log In	Log In	Log In	Upgrade
Operating Income (Total)	2.74B	2.63B	Log In	Log In	Log In	Upgrade

EBIT 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2018 - 2020
Patient Care Solutions (PCS) Segment EBIT	241.00M	347.00M	Log In	Log In	Log In	Upgrade
Pharmaceutical Diagnostics (PDx) Segment EBIT	850.00M	783.00M	Log In	Log In	Log In	Upgrade
Other Segment EBIT	6.00M	2.00M	Log In	Log In	Log In	Upgrade
Imaging Segment EBIT	-	-	Log In	Log In	Log In	Upgrade
Ultrasound Segment EBIT	-	-	Log In	Log In	Log In	Upgrade
Operating Income (Total)	2.74B	2.63B	Log In	Log In	Log In	Upgrade

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2018 - 2020
Products Remaining Performance Obligations (RPO)	4.90B	4.76B	Log In	Log In	Log In	Upgrade
Services Remaining Performance Obligations (RPO)	10.20B	9.74B	Log In	Log In	Log In	Upgrade
Total Remaining Performance Obligations (RPO)	15.10B	14.49B	Log In	Log In	Log In	Upgrade

Updated Oct 29, 2025. Data Source: Fiscal.ai.